Does the fine‐needle aspiration diagnosis of “Hürthle‐cell neoplasm/follicular neoplasm with oncocytic features” denote increased risk of malignancy?
暂无分享,去创建一个
[1] D. Myssiorek,et al. Hurthle Cell Neoplasms of the Thyroid , 2002, The Laryngoscope.
[2] Z. Baloch,et al. Intraoperative assessment of thyroid and parathyroid lesions. , 2002, Seminars in diagnostic pathology.
[3] A. Renshaw. How closely do thyroid fine‐needle aspirates need to be screened? , 2002, Diagnostic cytopathology.
[4] A. Renshaw. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine‐needle aspiration of the thyroid , 2002, Cancer.
[5] B. Delahunt,et al. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene. , 2002, The Journal of clinical endocrinology and metabolism.
[6] Z. Baloch,et al. Diagnosis of “follicular neoplasm”: A gray zone in thyroid fine‐needle aspiration cytology , 2002, Diagnostic cytopathology.
[7] K. Khurana,et al. Diagnostic utility of intracytoplasmic lumen and transgressing vessels in evaluation of Hürthle cell lesions by fine-needle aspiration. , 2001, Archives of pathology & laboratory medicine.
[8] M. Zou,et al. Cyclin D1 in thyroid carcinomas. , 2001, Thyroid : official journal of the American Thyroid Association.
[9] R. Spiro,et al. Hürthle cell carcinoma: a critical histopathologic appraisal. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] K. Azarow,et al. Does telomerase activity add to the value of fine needle aspirations in evaluating thyroid nodules? , 2001, American journal of surgery.
[11] W. Westra,et al. Randomized Prospective Evaluation of Frozen-Section Analysis for Follicular Neoplasms of the Thyroid , 2001, Annals of surgery.
[12] G. Fontanini,et al. Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index. , 2000, Thyroid : official journal of the American Thyroid Association.
[13] Z. Baloch,et al. Warthin-like papillary carcinoma of the thyroid. , 2000, Archives of pathology & laboratory medicine.
[14] J. Shah,et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996 , 2000, Cancer.
[15] A. Khiyami,et al. Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? , 1999, Surgery.
[16] M. Bibbo,et al. Differential Diagnosis of Oncocytic Lesions of the Breast and Thyroid Utilizing a Semiquantitative Approach , 1999, Acta Cytologica.
[17] D. Zelterman,et al. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. , 1999, The American journal of surgical pathology.
[18] G. Jayaram,et al. Fine needle aspiration cytology of the thyroid--a review of experience in 1853 cases. , 1999, The Malaysian journal of pathology.
[19] Z. Baloch,et al. Oncocytic Lesions of the Neuroendocrine System , 1999, Seminars in diagnostic pathology.
[20] I. Fleming,et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995 , 1998, Cancer.
[21] M. Silverman,et al. Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy. , 1998, Surgery.
[22] C. McHenry,et al. Management of follicular and Hürthle cell neoplasms of the thyroid gland. , 1998, Surgical oncology clinics of North America.
[23] S. Savin,et al. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. , 1998, Anticancer research.
[24] S. Piantadosi,et al. Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid. , 1998, The Journal of clinical endocrinology and metabolism.
[25] R. Tuttle,et al. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. , 1998, Thyroid : official journal of the American Thyroid Association.
[26] A. Kovatich,et al. Immunocytochemical evaluation of HBME‐1, CA 19‐9, and CD‐15 (Leu‐M1) in fine‐needle aspirates of thyroid nodules , 1998, Diagnostic cytopathology.
[27] D. Clark,et al. Polymerase chain reaction-based microsatellite analysis of fine-needle aspirations from Hürthle cell neoplasms. , 1997, Thyroid : official journal of the American Thyroid Association.
[28] N. Eberhardt,et al. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. , 1997, The Journal of clinical endocrinology and metabolism.
[29] H. Gharib,et al. Factors That Predict Malignant Thyroid Lesions When Fine-Needle Aspiration Is “Suspicious for Follicular Neoplasm” , 1997 .
[30] A. Venditti,et al. [Clinical significance of Hürthle cell in the cytology of thyroid disease]. , 1997, Recenti progressi in medicina.
[31] M. Miettinen,et al. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours , 1996, Virchows Archiv.
[32] G. Daniels,et al. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls. , 1996, Acta cytologica.
[33] S. Al-Sedairy,et al. The expression of the MDM2 gene, a p53 binding protein, in thyroid carcinogenesis , 1995, Cancer.
[34] D. Tyler,et al. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. , 1994, Surgery.
[35] R. Robins,et al. Clinical parameters predictive of malignancy of thyroid follicular neoplasms. , 1991, American journal of surgery.
[36] J. Rodier,et al. [Hürthle cell tumor of the thyroid gland. Analysis of a series of 33 cases]. , 1989, Journal de chirurgie.
[37] I. Hay,et al. Benign Hürthle cell tumors of the thyroid: A diagnosis to be trusted? , 1988, World Journal of Surgery.
[38] M. Bronner,et al. Flow cytometric analysis of DNA content in Hürthle cell adenomas and carcinomas of the thyroid. , 1988, American journal of clinical pathology.
[39] Joensuu,et al. DNA aneuploidy in follicular adenomas of the thyroid gland. , 1986, The American journal of pathology.
[40] E. Lerma,et al. Hürthle cell and mitochondrion‐rich cell tumors. A clinicopathologic study , 1986, Cancer.
[41] R. Lloyd,et al. Follicular carcinoma of the thyroid gland: trends and treatment. , 1984, Surgery.
[42] O. Clark,et al. Hürthle cell neoplasms. Malignant potential. , 1984, Archives of surgery.
[43] S. Gundry,et al. Total thyroidectomy for Hürthle cell neoplasm of the thyroid. , 1983, Archives of surgery.
[44] S. Kini,et al. Cytopathology of Hürthle cell lesions of the thyroid gland by fine needle aspiration. , 1981, Acta cytologica.
[45] Dunn El,et al. Hürthle cell lesions of the thyroid gland. , 1974, Surgery, gynecology & obstetrics.
[46] J. Hazard,et al. Atypical adenoma of the thyroid. , 1954, A.M.A. archives of pathology.
[47] Gilmore Hr,et al. Armed Forces Institute of Pathology. , 1968, Oral surgery, oral medicine, and oral pathology.
[48] D. Clark,et al. Beyond the suspicious thyroid fine needle aspirate. A review. , 2003, Acta cytologica.
[49] H. Gharib,et al. Factors that predict malignant thyroid lesions when fine-needle aspiration is "suspicious for follicular neoplasm". , 1997, Mayo Clinic proceedings.
[50] A. Bankfalvi,et al. Possible relation of p53 and mdm-2 oncoprotein expression in thyroid carcinoma: A molecular-pathological and immunohistochemical study on paraffin-embedded tissue , 1996, Endocrine pathology.
[51] V. Livolsi. The pathology of autoimmune thyroid disease: a review. , 1994, Thyroid : official journal of the American Thyroid Association.
[52] B. Cochand‐Priollet. [Follicular Hürthle cell tumors of the thyroid gland]. , 1992, Annales de pathologie.
[53] H. Rieger,et al. [The importance of atypical adenoma of the thyroid gland]. , 1988, Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie.
[54] S. Kini,et al. Cytopathology of thyroid nodules. , 1982, Henry Ford Hospital medical journal.
[55] M. Mosonyi. [Hürthle cell tumor of the thyroid gland]. , 1951, Kiserletes orvostudomany.